Your browser doesn't support javascript.
loading
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Chau, Cindy H; Price, Douglas K; Till, Cathee; Goodman, Phyllis J; Chen, Xiaohong; Leach, Robin J; Johnson-Pais, Teresa L; Hsing, Ann W; Hoque, Ashraful; Tangen, Catherine M; Chu, Lisa; Parnes, Howard L; Schenk, Jeannette M; Reichardt, Juergen K V; Thompson, Ian M; Figg, William D.
Afiliação
  • Chau CH; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Price DK; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Till C; Swog Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Goodman PJ; Swog Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Chen X; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Leach RJ; Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
  • Johnson-Pais TL; Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
  • Hsing AW; Cancer Prevention Institute of California, Fremont, California, Stanford Cancer Institute, Palo Alto, California, United States of America.
  • Hoque A; Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Tangen CM; Swog Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Chu L; Cancer Prevention Institute of California, Fremont, California, Stanford Cancer Institute, Palo Alto, California, United States of America.
  • Parnes HL; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Schenk JM; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Reichardt JK; School of Pharmacy and Molecular Sciences, James Cook University, Townsville, Queensland, Australia.
  • Thompson IM; Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
  • Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
PLoS One ; 10(5): e0126672, 2015.
Article em En | MEDLINE | ID: mdl-25955319
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Finasterida / Citocromo P-450 CYP3A Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Finasterida / Citocromo P-450 CYP3A Idioma: En Ano de publicação: 2015 Tipo de documento: Article